The beta adrenergic receptor antagonist propranolol alters mitogenic and apoptotic signaling in late stage breast cancer.

Montoya A, Varela-Ramirez A, Dickerson E, Pasquier E, Torabi A, Aguilera R, Nahleh Z, Bryan B. The beta adrenergic receptor antagonist propranolol alters mitogenic and apoptotic signaling in late stage breast cancer. Biomed J. 2019 06; 42(3):155-165.

View in: PubMed

subject areas

Adrenergic beta-Antagonists
Apoptosis
Breast Neoplasms
Cell Line, Tumor
Cell Proliferation
Humans
Propranolol
Prospective Studies
Signal Transduction
Treatment Outcome

authors with profiles

Renato J. Aguilera

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support